Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand Up 2 cancer study
Oncotarget | February 7, 2017 | Volume: 8 | Issue: 21 | Pages: 35326-35338
10.18632/oncotarget.15108
| PMID 28186961